DESIGN AND METHODS: We studied serum levels of IGF-I and IGFBP-3 in 68 pregnant women; 28 mild preeclampsia, 13 severe preeclampsia, and 27 healthy pregnant control subjects. RESULTS: When compared with the healthy pregnant group preeclampsia groups had markedly decreased mean serum IGF-I levels. The difference was also significant between the mild and severe preeclampsia groups. Serum mean IGFBP-3 level was also lower in both preeclampsia groups than in healthy pregnancy group, but the difference between the preeclampsia groups did not reach significance. For IGF-I/IGFBP-3 ratio, the mean levels were significantly lower in mild and severe preeclampsia groups than in healthy pregnancy group. Also the mean IGF-I/IGFBP-3 ratio was significantly lower in the severe preeclampsia group compared with the mild preeclampsia group. CONCLUSIONS: IGF-1 and IGFBP-3 levels in patients with preeclampsia were compared with healthy pregnant control subjects. IGF-I and IGF-I/IGFBP-3 ratio may be useful for estimate the severity of preeclampsia.
DESIGN AND METHODS: We studied serum levels of IGF-I and IGFBP-3 in 68 pregnant women; 28 mild preeclampsia, 13 severe preeclampsia, and 27 healthy pregnant control subjects. RESULTS: When compared with the healthy pregnant group preeclampsia groups had markedly decreased mean serum IGF-I levels. The difference was also significant between the mild and severe preeclampsia groups. Serum mean IGFBP-3 level was also lower in both preeclampsia groups than in healthy pregnancy group, but the difference between the preeclampsia groups did not reach significance. For IGF-I/IGFBP-3 ratio, the mean levels were significantly lower in mild and severe preeclampsia groups than in healthy pregnancy group. Also the mean IGF-I/IGFBP-3 ratio was significantly lower in the severe preeclampsia group compared with the mild preeclampsia group. CONCLUSIONS:IGF-1 and IGFBP-3 levels in patients with preeclampsia were compared with healthy pregnant control subjects. IGF-I and IGF-I/IGFBP-3 ratio may be useful for estimate the severity of preeclampsia.
Authors: Huiyan Ma; Katherine D Henderson; Jane Sullivan-Halley; Lei Duan; Sarah F Marshall; Giske Ursin; Pamela L Horn-Ross; Joan Largent; Dennis M Deapen; James V Lacey; Leslie Bernstein Journal: Breast Cancer Res Date: 2010-06-18 Impact factor: 6.466
Authors: Mark J Powell; Julie Von Behren; Susan Neuhausen; Peggy Reynolds; Christopher C Benz Journal: Cancer Causes Control Date: 2017-08-18 Impact factor: 2.506
Authors: Lauren B Wright; Minouk J Schoemaker; Michael E Jones; Alan Ashworth; Anthony J Swerdlow Journal: Int J Cancer Date: 2018-03-23 Impact factor: 7.396
Authors: Lee Ann Prebil; Rochelle R Ereman; Mark J Powell; Farid Jamshidian; Karla Kerlikowske; John A Shepherd; Marc S Hurlbert; Christopher C Benz Journal: Cancer Causes Control Date: 2014-05-07 Impact factor: 2.506